Total Lab Automation Market

Total Lab Automation Market: Industry Trends and Global Forecasts, Till 2035 - Application (Diagnostics, Genomic Solutions, Microbiology, Drug Discovery, Proteomic Solutions and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Research and Diagnostic Laboratories and Other End-Users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America)

  • Lowest Price Guaranteed

  • Pages
    235

  • Last Updated
    June 2026

  • View Count
    14815

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Inclusions and Exclusions
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates

3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry

3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Rise

3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION
5.1. Chapter Overview
5.2. Overview of Lab Automation
5.3. Historical Evolution of Lab Automation
5.4. Total lab Automation
5.5. Advantages of Total Lab Automation
5.6. Challenges associated with Total Lab Automation
5.7. Future Perspectives

6. MARKET LANDSCAPE
6.1. Total Lab Automation System Manufacturers: Overall Market Landscape
6.1.1. Analysis by Year of Establishment
6.1.2. Analysis by Company Size
6.1.3. Analysis by Location of Headquarters
6.1.4. Analysis by Company Size and Location of Headquarters
6.1.5. Analysis by Type of Lab Automation System(s)
6.1.6. Analysis by Type of Automated Liquid Handler(s)
6.1.7. Analysis by Type of Automated Microplate(s)
6.1.8. Analysis by Application Area(s)
6.1.9. Analysis by Type of Lab Automation System(s) and Application Area(s)
6.1.10. Analysis by End-user(s)

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Assumptions and Key Parameters
7.2 Methodology
7.3. Competitiveness Analysis: Very Small Companies based in North America (Peer Group I)
7.4. Competitiveness Analysis: Small Companies based in North America (Peer Group II)
7.5 Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
7.6. Competitiveness Analysis: Large Companies based in North America (Peer Group IV)
7.7. Competitiveness Analysis: Very Large Companies based in North America (Peer Group V)
7.8 Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI)
7.9 Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
7.10. Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VII)
7.11. Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
7.12. Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X)
7.13. Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI)
7.14. Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII)
7.15. Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII)
7.16. Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV)
7.17. Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV)

8. COMPANY PROFILES
8.1. Abbott
8.1.1. Company Overview
8.1.2. Financial Information
8.1.3. Total Lab Automation Product Portfolio
8.1.4. Recent Developments and Future Outlook

8.2. Anton Paar
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Total Lab Automation Product Portfolio
8.2.4. Recent Developments and Future Outlook

8.3. BD
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Total Lab Automation Product Portfolio
8.3.4. Recent Developments and Future Outlook

8.4. Beckman Coulter
8.4.1. Company Overview
8.4.2. Financial Information
8.4.3. Total Lab Automation Product Portfolio
8.4.4. Recent Developments and Future Outlook

8.5. ERWEKA
8.5.1. Company Overview
8.5.2. Financial Information
8.5.3. Total Lab Automation Product Portfolio
8.5.4. Recent Developments and Future Outlook

8.6. Leuze
8.6.1. Company Overview
8.6.2. Financial Information
8.6.3. Total Lab Automation Product Portfolio
8.6.4. Recent Developments and Future Outlook

8.7. Ortho Clinical Diagnostics
8.7.1. Company Overview
8.7.2. Financial Information
8.7.3. Total Lab Automation Product Portfolio
8.7.4. Recent Developments and Future Outlook

8.8. Pall Corporation
8.8.1. Company Overview
8.8.2. Financial Information
8.8.3. Total Lab Automation Product Portfolio
8.8.4. Recent Developments and Future Outlook

8.9. PerkinElmer
8.9.1. Company Overview
8.9.2. Financial Information
8.9.3. Total Lab Automation Product Portfolio
8.9.4. Recent Developments and Future Outlook

8.10. Roche Diagnostics
8.10.1. Company Overview
8.10.2. Financial Information
8.10.3. Total Lab Automation Product Portfolio
8.10.4. Recent Developments and Future Outlook 

8.11. Siemens Healthineers
8.11.1. Company Overview
8.11.2. Financial Information
8.11.3. Total Lab Automation Product Portfolio
8.11.4. Recent Developments and Future Outlook

8.12. SYSTAG
8.12.1. Company Overview
8.12.2. Financial Information
8.12.3. Total Lab Automation Product Portfolio
8.12.4. Recent Developments and Future Outlook

9. CASE STUDY: TOTAL LAB AUTOMATION SOFTWARE
9.1. Total Lab Automation Software Providers: Overall Market Landscape
9.1.1. Analysis by Year of Establishment
9.1.2. Analysis by Company Size
9.1.3. Analysis by Location of Headquarters
9.1.4. Analysis by Company Size and Location of Headquarters
9.1.5. Analysis by Type of Software
9.1.6. Analysis by Mode of Deployment
9.1.7. Analysis by Type of Software and Mode of Deployment
9.1.8. Analysis by End-user
9.1.9. Analysis by Type of Software and End-user

10. PARTNERSHIPS AND COLLABORATIONS
10.1. Partnership Models
10.2. Total Lab Automation: List of Partnerships and Collaborations
10.2.1. Analysis by Year of Partnership
10.2.2. Analysis by Type of Partnership
10.2.3. Analysis by Year and Type of Partnership
10.2.4. Analysis by Type of Partner
10.2.5. Analysis by Year of Partnership and Type of Partner
10.2.6. Analysis by Type of Partnership and Type of Partner
10.2.7. Analysis by Type of Automation Instrument(s)
10.2.8. Analysis by Type of Partnership and Automation Instrument(s)
10.2.9. Most Active Players: Analysis by Number of Partnerships

10.2.10. Analysis by Geography
10.2.10.1. Local and International Agreements
10.2.10.2. Intracontinental and Intercontinental Agreements

11. PATENT ANALYSIS
11.1. Methodology and Key Parameters
11.2. Total Lab Automation: List of Patents
11.3. Analysis by Patent Publication Year
11.4. Analysis by Publication Year and Type of Patent
11.5. Analysis by Application Year
11.6. Analysis by Patent Jurisdiction
11.7. Analysis by CPC Symbols
11.8. Analysis by Type of Applicant
11.9. Word Cloud: Emerging Focus Areas
11.10. Analysis by Patent Age
11.11. Leading Industry Players: Analysis by Number of Patents
11.12. Leading Non-Industry Players: Analysis by Number of Patents
11.13. Leading Individual Assignees: Analysis by Number of Patents
11.14. Patent Benchmarking: Analysis of Leading Industry Players by Patent Characterization (CPC Symbols)

11.15. Patent Valuation: Methodology and Key Parameters
11.15.1. Analysis by Relative Patent Valuation

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion

13. GLOBAL TOTAL LAB AUTOMATION MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Total Lab Automation Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.3.1. Scenario Analysis
13.3.1.1. Conservative Scenario Analysis
13.3.1.2. Optimistic Scenario Analysis

13.4. Key Market Segmentations
13.5. Dynamic Dashboards

14. TOTAL LAB AUTOMATION MARKET, BY APPLICATION
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Total lab Automation Market: Distribution by Application, 2023 and 2035
14.3.1. Diagnostics: Forecasted Estimates (2023-2035)
14.3.2. Genomic Solutions: Forecasted Estimates (2023-2035)
14.3.3. Microbiology: Forecasted Estimates (2023-2035)
14.3.4. Drug Discovery: Forecasted Estimates (2023-2035)
14.3.5. Proteomic Solutions: Forecasted Estimates (2023-2035)
14.3.6. Other Applications: Forecasted Estimates (2023-2035)

14.4. Data Triangulation and Validation

15. TOTAL LAB AUTOMATION MARKET, BY END USER
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Total Lab Automation Market, by End user, 2023 and 2035
15.3.1. Biotechnology and Pharmaceutical Industries: Forecasted Estimates (2023-2035)
15.3.2. Research and Academic Institutes: Forecasted Estimates (2023-2035)
15.3.3. Other End users: Forecasted Estimates (2023-2035)

15.4. Data Triangulation and Validation

16. TOTAL LAB AUTOMATION MARKET, BY KEY GEOGRAPHICAL REGION
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Total lab Automation Market: Distribution by Key Geographical Regions, 2023 and 2035
16.3.1. North America: Forecasted Estimates (2023-2035)
16.3.2. Europe: Forecasted Estimates (2023-2035)
16.3.3. Asia-Pacific: Forecasted Estimates (2023-2035)
16.3.4. Middle East and North Africa: Forecasted Estimates (2023-2035)
16.3.5. Latin America: Forecasted Estimates (2023-2035)

17. EXECUTIVE INSIGHTS
17.1. Chapter Overview
17.2. Africa Medical Supplies Platform
17.2.1. Company Overview
17.2.2. Interview Transcript

17.3. A.S.T. Biomedical
17.3.1. Company Overview
17.3.2. Interview Transcript

17.4. Berthold Technologies
17.4.1. Company Overview
17.4.2. Interview Transcript

17.5. Efevre Tech
17.5.1. Company Overview
17.5.2. Interview Transcript

17.6. HSE
17.6.1. Company Overview
17.6.2. Interview Transcript

17.7. Inheco
17.7.1. Company Overview
17.7.2. Interview Transcript

17.8. LabWare
17.8.1. Company Overview
17.8.2. Interview Transcript

17.9. SciRobotics
17.9.1. Company Overview
17.9.2. Interview Transcript

18. CONCLUSION

19. APPENDIX 1: TABULATED DATA

20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Overall Market Landscape of Total Lab Automation System Manufacturers
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Patent Analysis
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Historical Evolution of Lab Automation
Figure 5.2 Process Involved in Total Lab Automation
Figure 5.3 Advantages of Total Lab Automation Over Manual Handling
Figure 6.1 Total Lab Automation System Manufacturers: Distribution by Year of Establishment
Figure 6.2 Total Lab Automation System Manufacturers: Distribution by Company Size
Figure 6.3 Total Lab Automation System Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 6.4 Total Lab Automation System Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 6.5 Total Lab Automation System Manufacturers: Distribution by Company Size and Location of Headquarters (Region-wise)
Figure 6.6 Total Lab Automation System Manufacturers: Distribution by Type of Lab Automation System(s)
Figure 6.7 Total Lab Automation System Manufacturers: Distribution by Type of Automated Liquid Handling System(s)
Figure 6.8 Total Lab Automation System Manufacturers: Distribution by Type of Automated Microplate(s)
Figure 6.9 Total Lab Automation System Manufacturers: Distribution by Application Area(s)
Figure 6.10 Total Lab Automation System Manufacturers: Distribution by Type of Total Lab Automation system(s) and Application Area(s)
Figure 6.11 Total Lab Automation System Manufacturers: Distribution by End user(s)
Figure 7.1 Company Competitiveness Analysis: Very Small Companies based in North America (Peer Group I)
Figure 7.2 Company Competitiveness Analysis: Small Companies based in North America (Peer Group II)
Figure 7.3 Company Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
Figure 7.4 Company Competitiveness Analysis: Large Companies based in North America (Peer Group IV)
Figure 7.5 Company Competitiveness Analysis: Very Large Companies based in North America (Peer Group V)
Figure 7.6 Company Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI)
Figure 7.7 Company Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
Figure 7.8 Company Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VIII)
Figure 7.9 Company Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
Figure 7.10 Company Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X)
Figure 7.11 Company Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI)
Figure 7.12 Company Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII)
Figure 7.13 Company Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII)
Figure 7.14 Company Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV)
Figure 7.15 Company Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV)
Figure 8.1 Abbott: Annual Revenues, 2018-2022 (USD Billion)
Figure 8.2 Abbott: Product Portfolio
Figure 8.3 Anton Paar: Product Portfolio
Figure 8.4 BD: Annual Revenues, FY 2018-Q1 FY 2023 (USD Billion)
Figure 8.5 BD: Product Portfolio
Figure 8.6 Danaher (Parent Company of Beckman Coulter): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Figure 8.7 Beckman Coulter: Product Portfolio
Figure 8.8 ERWEKA: Product Portfolio
Figure 8.9 Leuze: Product Portfolio
Figure 8.10 Ortho Clinical Diagnostics: Annual Revenues, FY 2019-FY 2022 (USD Billion)
Figure 8.11 Ortho Clinical Diagnostics: Product Portfolio
Figure 8.12 Danaher (Parent Company of Pall Corporation): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Figure 8.13 Pall Corporation: Product Portfolio
Figure 8.14 PerkinElmer: Annual Revenues, FY 2018-FY 2022 (USD Billion)
Figure 8.15 PerkinElmer: Product Portfolio
Figure 8.16 Roche Diagnostics: Annual Revenues, FY 2018-FY 2022 (CHF Billion)
Figure 8.17 Roche Diagnostics: Product Portfolio
Figure 8.18 Siemens Healthineers: Annual Revenues, FY 2018-Q1 FY 2023 (Euro Billion)
Figure 8.19 Siemens Healthineers: Product Portfolio
Figure 8.20 SYSTAG: Product Portfolio
Figure 9.1 Total Lab Automation Software Providers: Distribution by Year of Establishment
Figure 9.2 Total Lab Automation Software Providers: Distribution by Company Size
Figure 9.3 Total Lab Automation Software Providers: Distribution by Location of Headquarters (Region-wise)
Figure 9.4 Total Lab Automation Software Providers: Distribution by Location of Headquarters (Country-wise)
Figure 9.5 Total Lab Automation Software Providers: Distribution by Company Size and Location of Headquarters (Region-wise)
Figure 9.6 Total Lab Automation Software Providers: Distribution by Type of Software
Figure 9.7 Total Lab Automation Software Providers: Distribution by Mode(s) of Deployment
Figure 9.8 Total Lab Automation Software Providers: Distribution by Type of Software and Mode(s) of Deployment
Figure 9.9 Total Lab Automation Software Providers: Distribution by End-user(s)
Figure 9.10 Total Lab Automation Software Providers: Distribution by Type of Software and End-user(s)
Figure 10.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 10.6 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 10.7 Partnerships and Collaborations: Distribution by Type of Automation Instrument(s) Used
Figure 10.8 Most Active Players: Distribution by Number of Partnerships
Figure 10.9 Partnerships and Collaborations: Local and International Agreements
Figure 10.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 11.1 Patent Analysis: Distribution by Patent Publication Year
Figure 11.2 Patent Analysis: Distribution by Publication Year and Type of Patent
Figure 11.3 Patent Analysis: Distribution by Application Year
Figure 11.4 Patent Analysis: Distribution by Patent Jurisdiction
Figure 11.5 Patent Analysis: Distribution by CPC Symbols
Figure 11.6 Patent Analysis: Cumulative Distribution by Type of Applicant
Figure 11.7 Word Cloud: Emerging Focus Areas
Figure 11.8 Patent Analysis: Distribution by Patent Age
Figure 11.9 Leading Industry Players: Distribution by Number of Patents
Figure 11.10 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.11 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.12 Patent Benchmarking: Distribution of Leading Industry Players by Patent Characterization (CPC Symbols)
Figure 11.13 Patent Valuation: Distribution by Relative Patent Valuation
Figure 12.1 Market Drivers
Figure 12.2 Market Restraints
Figure 12.3 Market Opportunities
Figure 12.4 Market Challenges
Figure 13.1 Global Total Lab Automation Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 13.2 Global Total Lab Automation Market, 2023-2035: Conservative Scenario (USD Million)
Figure 13.3 Global Total Lab Automation Market, 2023-2035: Optimistic Scenario (USD Million)
Figure 14.1 Total Lab Automation Market: Distribution by Application, 2023 and 2035 (USD Million)
Figure 14.2 Total Lab Automation Market for Diagnostics: Forecasted Estimates (2023-2035) (USD Million)
Figure 14.3 Total Lab Automation Market for Genomic Solutions: Forecasted Estimates (2023-2035) (USD Million)
Figure 14.4 Total Lab Automation Market for Microbiology: Forecasted Estimates (2023-2035) (USD Million)
Figure 14.5 Total Lab Automation Market for Drug Discovery: Forecasted Estimates (2023-2035) (USD Million)
Figure 14.6 Total Lab Automation Market for Proteomic Solutions: Forecasted Estimates (2023-2035) (USD Million)
Figure 14.7 Total Lab Automation Market for Other Applications: Forecasted Estimates (2023-2035) (USD Million)
Figure 15.1 Total Lab Automation Market: Distribution by End User, 2023 and 2035 (USD Million)
Figure 15.2 Total Lab Automation Market for Biotechnology and Pharmaceutical Industries: Forecasted Estimates (2023-2035) (USD Million)
Figure 15.3 Total Lab Automation Market for Research and Academic Institutes: Forecasted Estimates (2023-2035) (USD Million)
Figure 15.4 Total Lab Automation Market for Other End Users: Forecasted Estimates (2023-2035) (USD Million)
Figure 16.1 Total Lab Automation Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)
Figure 16.2 Total Lab Automation Market in North America: Forecasted Estimates (2023-2035) (USD Million)
Figure 16.3 Total Lab Automation Market in Europe: Forecasted Estimates (2023-2035) (USD Million)
Figure 16.4 Total Lab Automation Market in Asia-Pacific: Forecasted Estimates (2023-2035) (USD Million)
Figure 16.5 Total Lab Automation Market in Middle East and North Africa: Forecasted Estimates (2023-2035) (USD Million)
Figure 16.6 Total Lab Automation Market in Latin America: Forecasted Estimates (2023-2035) (USD Million)

List Of Tables

Table 6.1 Total Lab Automation System Manufacturers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.2 Total Lab Automation System Manufacturers: Information on Type of Automated Instrument(s)
Table 6.3 Total Lab Automation System Manufacturers: Information on Stage(s) of Automation, Application Area(s) and End-user(s)
Table 8.1 Abbott: Total Lab Automation Products
Table 8.2 Abbott: Recent Developments and Future Outlook
Table 8.3 Anton Paar: Total Lab Automation Products
Table 8.4 Anton Paar: Future Outlook
Table 8.5 BD: Total Lab Automation Products
Table 8.6 BD: Recent Developments and Future Outlook
Table 8.7 Beckman Coulter: Total Lab Automation Products
Table 8.8 Beckman Coulter: Recent Developments and Future Outlook
Table 8.9 ERWEKA: Total Lab Automation Products
Table 8.10 ERWEKA: Recent Developments and Future Outlook
Table 8.11 Leuze: Total Lab Automation Products
Table 8.12 Leuze: Recent Developments and Future Outlook
Table 8.13 Ortho Clinical Diagnostics: Total Lab Automation Products
Table 8.14 Ortho Clinical Diagnostics: Recent Developments and Future Outlook
Table 8.15 Pall Corporation: Total Lab Automation Products
Table 8.16 Pall Corporation: Recent Developments and Future Outlook
Table 8.17 PerkinElmer: Total Lab Automation Products
Table 8.18 PerkinElmer: Recent Developments and Future Outlook
Table 8.19 Roche Diagnostics: Total Lab Automation Products
Table 8.20 Roche Diagnostics: Recent Developments and Future Outlook
Table 8.21 Siemens Healthineers: Total Lab Automation Products
Table 8.22 Siemens Healthineers: Recent Developments and Future Outlook
Table 8.23 SYSTAG: Total Lab Automation Products
Table 8.24 SYSTAG: Recent Developments and Future Outlook
Table 9.1 Lab Automation Software Providers: Information on Location of Headquarters, Company Size, Type of Software, Mode(s) of Deployment and End-User(s)
Table 10.1 Total Lab Automation: List of Partnerships and Collaborations
Table 11.1 Lab Automation: List of Filed / Granted Patents
Table 11.2 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 20.1 Total Lab Automation System Manufacturers: Distribution by Year of Establishment
Table 20.2 Total Lab Automation System Manufacturers: Distribution by Company Size
Table 20.3 Total Lab Automation System Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 20.4 Total Lab Automation System Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 20.5 Total Lab Automation System Manufacturers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 20.6 Total Lab Automation System Manufacturers: Distribution by Type of Lab Automation System(s)
Table 20.7 Total Lab Automation System Manufacturers: Distribution by Type of Automated Liquid Handling System(s)
Table 20.8 Total Lab Automation System Manufacturers: Distribution by Type of Automated Microplate(s)
Table 20.9 Total Lab Automation System Manufacturers: Distribution by Application Area(s)
Table 20.10 Total Lab Automation System Manufacturers: Distribution by Type of Total Lab Automation system(s) and Application Area(s)
Table 20.11 Total Lab Automation System Manufacturers: Distribution by End user(s)
Table 20.12 Abbott: Annual Revenues, 2018-2022 (USD Billion)
Table 20.13 Abbott: Product Portfolio
Table 20.14 Anton Paar: Product Portfolio
Table 20.15 BD: Annual Revenues, FY 2018-Q1 FY 2023 (USD Billion)
Table 20.16 BD: Product Portfolio
Table 20.17 Danaher (Parent Company of Beckman Coulter): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Table 20.18 Beckman Coulter: Product Portfolio
Table 20.19 ERWEKA: Product Portfolio
Table 20.20 Leuze: Product Portfolio
Table 20.21 Ortho Clinical Diagnostics: Annual Revenues, FY 2019-FY 2022 (USD Billion)
Table 20.22 Ortho Clinical Diagnostics: Product Portfolio
Table 20.23 Danaher (Parent Company of Pall Corporation): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Table 20.24 Pall Corporation: Product Portfolio
Table 20.25 PerkinElmer: Annual Revenues, FY 2018-FY 2022 (USD Billion)
Table 20.26 PerkinElmer: Product Portfolio
Table 20.27 Roche Diagnostics: Annual Revenues, FY 2018-FY 2022 (CHF Billion)
Table 20.28 Roche Diagnostics: Product Portfolio
Table 20.29 Siemens Healthineers: Annual Revenues, FY 2018-Q1 FY 2023 (Euro Billion)
Table 20.30 Siemens Healthineers: Product Portfolio
Table 20.31 SYSTAG: Product Portfolio
Table 20.32 Total Lab Automation Software Providers: Distribution by Year of Establishment
Table 20.33 Total Lab Automation Software Providers: Distribution by Company Size
Table 20.34 Total Lab Automation Software Providers: Distribution by Location of Headquarters (Region-wise)
Table 20.35 Total Lab Automation Software Providers: Distribution by Location of Headquarters (Country-wise)
Table 20.36 Total Lab Automation Software Providers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 20.37 Total Lab Automation Software Providers: Distribution by Type of Software
Table 20.38 Total Lab Automation Software Providers: Distribution by Mode(s) of Deployment
Table 20.39 Total Lab Automation Software Providers: Distribution by Type of Software and Mode(s) of Deployment
Table 20.40 Total Lab Automation Software Providers: Distribution by End-user(s)
Table 20.41 Total Lab Automation Software Providers: Distribution by Type of Software and End-user(s)
Table 20.42 Partnerships and Collaborations: Distribution by Year of Partnership
Table 20.43 Partnerships and Collaborations: Distribution by Type of Partnership
Table 20.44 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 20.45 Partnerships and Collaborations: Distribution by Type of Partner 
Table 20.46 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 20.47 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 20.48 Partnerships and Collaborations: Distribution by Type of Automation Instrument(s) Used
Table 20.49 Most Active Players: Distribution by Number of Partnerships
Table 20.50 Partnerships and Collaborations: Local and International Agreements
Table 20.51 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 20.52 Patent Analysis: Distribution by Patent Publication Year
Table 20.53 Patent Analysis: Distribution by Publication Year and Type of Patent
Table 20.54 Patent Analysis: Distribution by Application Year
Table 20.55 Patent Analysis: Distribution by Patent Jurisdiction
Table 20.56 Patent Analysis: Distribution by CPC Symbols
Table 20.57 Patent Analysis: Cumulative Distribution by Type of Applicant
Table 20.58 Patent Analysis: Distribution by Patent Age
Table 20.59 Leading Industry Players: Distribution by Number of Patents
Table 20.60 Leading Non-Industry Players: Distribution by Number of Patents
Table 20.61 Leading Individual Assignees: Distribution by Number of Patents
Table 20.62 Patent Benchmarking: Distribution of Leading Industry Players by Patent Characterization (CPC Symbols)
Table 20.63 Patent Valuation: Distribution by Relative Patent Valuation
Table 20.64 Global Total Lab Automation Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 20.65 Global Total Lab Automation Market, 2023-2035: Conservative Scenario (USD Million)
Table 20.66 Global Total Lab Automation Market, 2023-2035: Optimistic Scenario (USD Million)
Table 20.67 Total Lab Automation Market: Distribution by Application, 2023 and 2035 (USD Million)
Table 20.68 Total Lab Automation Market for Diagnostics: Forecasted Estimates (2023-2035) (USD Million)
Table 20.69 Total Lab Automation Market for Genomic Solutions: Forecasted Estimates (2023-2035) (USD Million)
Table 20.70 Total Lab Automation Market for Microbiology: Forecasted Estimates (2023-2035) (USD Million)
Table 20.71 Total Lab Automation Market for Drug Discovery: Forecasted Estimates (2023-2035) (USD Million)
Table 20.72 Total Lab Automation Market for Proteomic Solutions: Forecasted Estimates (2023-2035) (USD Million)
Table 20.73 Total Lab Automation Market for Other Applications: Forecasted Estimates (2023-2035) (USD Million)
Table 20.74 Total Lab Automation Market: Distribution by End User, 2023 and 2035 (USD Million)
Table 20.75 Total Lab Automation Market for Biotechnology and Pharmaceutical Industries: Forecasted Estimates (2023-2035) (USD Million)
Table 20.76 Total Lab Automation Market for Research and Academic Institutes: Forecasted Estimates (2023-2035) (USD Million)
Table 20.77 Total Lab Automation Market for Other End Users: Forecasted Estimates (2023-2035) (USD Million)
Table 20.78 Total Lab Automation Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)
Table 20.79 Total Lab Automation Market in North America: Forecasted Estimates (2023-2035) (USD Million)
Table 20.80 Total Lab Automation Market in Europe: Forecasted Estimates (2023-2035) (USD Million)
Table 20.81 Total Lab Automation Market in Asia-Pacific: Forecasted Estimates (2023-2035) (USD Million)
Table 20.82 Total Lab Automation Market in Middle East and North Africa: Forecasted Estimates (2023-2035) (USD Million)
Table 20.83 Total Lab Automation Market in Latin America: Forecasted Estimates (2023-2035) (USD Million)

List Of Companies

The following companies and organizations have been mentioned in this report.

  1. AB Controls
  2. Abbott
  3. Aim Lab Automation Technologies
  4. ALIFAX
  5. Anton Paar
  6. Autobio Diagnostics
  7. Automata
  8. BD
  9. Beckman Coulter
  10. Biometer
  11. BioNex Solutions
  12. Chirus
  13. COPAN Diagnostics
  14. EFEVRE TECH
  15. ERWEKA
  16. GERSTEL
  17. GeSiM
  18. HSE•AG
  19. Inpeco
  20. Intense Engineering
  21. Labmate Asia
  22. LAMBDA Laboratory Instruments
  23. Leuze
  24. MEGAROBO
  25. MGI
  26. Molecular Devices
  27. Neotec Bio
  28. Nova Biomedical
  29. Ortho Clinical Diagnostics
  30. Pall Corporation
  31. Peak Analysis and Automation
  32. PerkinElmer
  33. Randox Laboratories
  34. RBC Bioscience
  35. Rhinostics
  36. RIDACOM
  37. Roche Diagnostics
  38. Siemens Healthineers
  39. STRATEC
  40. SYSTAG
  41. TIANGEN BIOTECH
  42. TransGen Biotech
  43. Unchained Labs
  44. Valin
  45. Vazyme Biotech
  46. Vela Diagnostics